Intelligence Platform
Patents
Browse 677 pharma-relevant US patents (A61K/A61P) linked to tracked companies. Patent cliff and LOE intelligence for BD teams.
US 7723096
Agonist peptides of carcinoembryonic antigen (CEA) and nucleic acid sequences encoding the
granted patentUS 7723111
Activated dual specificity lymphocytes and their methods of use
granted patentUS 7718196
Rapamycin-resistant T cells and therapeutic uses thereof
granted patentUS 7718424
AAV4 vector and uses thereof
granted patentUS 7713529
Methods for treating and preventing infectious disease
granted patentUS 7709002
Mutated ras peptides for generation of CD8+Cytotoxic T lymphocytes
granted patentUS 7709007
Production of attenuated respiratory syncytial virus vaccines from cloned nucleotide seque
granted patentUS 7709252
Antibodies, including FV molecules, and immunoconjugates having high binding affinity for
granted patentUS 7704491
Recombinant human metapneumovirus and its use
granted patentUS 7700273
Peptidomimetics that mimic a conformational-dependent neutralizing epitope of the human im
granted patentUS 7696338
Immunotoxin fusion proteins and means for expression thereof
granted patentUS 7687610
Human chorionic gonadotropin superagonists
granted patentUS 7678569
Cloned genome of infectious hepatitis C virus strain HC-TN and uses thereof
granted patentUS 7674777
Immunostimulatory nucleic acid molecules
granted patentUS 7670806
ADP-ribosyl acceptor hydrolase 3 (ARH3) polypeptides and methods of use
granted patentUS 7666411
Methods of treating and preventing colitis involving IL-13 and NK-T cells
granted patentUS 7666846
Cholesterol-containing compounds and their use as immunogens against Borrelia burgdorferi
granted patentUS 7662397
Respiratory syncytial virus vaccines expressing protective antigens from promoter-proximal
granted patentUS 7662573
Methods for evaluating osteoarthritis risk
granted patentUS 7662394
Nucleic acids encoding chimeric Flavivirus immunogens comprising the Japanese encephalitis
granted patentUS 7662395
Method of enhancing a targeted immune response against tumors
granted patentUS 7658364
Ocular therapeutic agent delivery devices and methods for making and using such devices
granted patentUS 7655397
Selections of genes and methods of using the same for diagnosis and for targeting the ther
granted patentUS 7655694
Phytoestrogenic isoflavone compositions, their preparation and use thereof for protection
granted